Eleven

Curated by Signal

AI-based RNA drug development platform for researchers

Overview

AI-based RNA drug development platform for researchers. The company harnesses the power of combinatorial chemistry and AI to transform RNAi drug development into a programmable process against influenza and SARS-CoV-2.

Key facts

Founded: 2020
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

BenFit
Provider of a software for nutritionist and gym for customized meal plans
Health TechnologyHertfordshire, United Kingdom
Neurodiverse Connection
Online community suppoert for neurodivergent people
Health TechnologyLondon, United Kingdom
Conserus
Digital EHR management tool for providers
Health TechnologyLondon, United Kingdom

About Eleven

What does Eleven do?

AI-based RNA drug development platform for researchers.

Where is Eleven headquartered?

Eleven is headquartered in Cambridge, United Kingdom.

When was Eleven founded?

Eleven was founded in 2020.

Which sector is Eleven in?

Eleven operates in Health Technology.

Who are Eleven's competitors?

Companies similar to Eleven include BenFit, Neurodiverse Connection, and Conserus.